Predicting changes in the pharmacokinetics of CYP3A‐metabolized drugs in hepatic impairment and insights into factors driving these changes

Physiologically based pharmacokinetic models, populated with drug‐metabolizing enzyme and transporter (DMET) abundance, can be used to predict the impact of hepatic impairment (HI) on the pharmacokinetics (PK) of drugs. To increase confidence in the predictive power of such models, they must be vali...

Descripción completa

Detalles Bibliográficos
Autores principales: Ladumor, Mayur K., Storelli, Flavia, Liang, Xiaomin, Lai, Yurong, Enogieru, Osatohanmwen J., Chothe, Paresh P., Evers, Raymond, Unadkat, Jashvant D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931433/
https://www.ncbi.nlm.nih.gov/pubmed/36540952
http://dx.doi.org/10.1002/psp4.12901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931433/
https://www.ncbi.nlm.nih.gov/pubmed/36540952
http://dx.doi.org/10.1002/psp4.12901

Ejemplares similares